Swiss National Bank bought a new stake in shares of Surgery Partners Inc. (NASDAQ:SGRY) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 36,700 shares of the company’s stock, valued at approximately $657,000. Swiss National Bank owned about 0.08% of Surgery Partners at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Royal Bank of Canada boosted its stake in shares of Surgery Partners by 3.9% in the first quarter. Royal Bank of Canada now owns 9,634 shares of the company’s stock valued at $129,000 after buying an additional 366 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Surgery Partners by 3.8% in the first quarter. BlackRock Inc. now owns 17,116 shares of the company’s stock valued at $227,000 after buying an additional 632 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Surgery Partners by 1.5% in the first quarter. Geode Capital Management LLC now owns 140,338 shares of the company’s stock valued at $1,860,000 after buying an additional 2,103 shares during the last quarter. California State Teachers Retirement System boosted its stake in shares of Surgery Partners by 16.3% in the second quarter. California State Teachers Retirement System now owns 39,033 shares of the company’s stock valued at $699,000 after buying an additional 5,468 shares during the last quarter. Finally, Bellevue Group AG bought a new stake in shares of Surgery Partners during the first quarter valued at approximately $133,000. Institutional investors and hedge funds own 38.32% of the company’s stock.
Shares of Surgery Partners Inc. (NASDAQ:SGRY) traded up 2.261% during trading on Wednesday, hitting $20.125. The company had a trading volume of 80,638 shares. The firm has a market capitalization of $976.67 million and a P/E ratio of 108.784. Surgery Partners Inc. has a 1-year low of $11.76 and a 1-year high of $22.32. The company’s 50 day moving average is $19.35 and its 200 day moving average is $16.71.
Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Tuesday, August 9th. The company reported $0.16 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.14 by $0.02. The business earned $289.70 million during the quarter, compared to analyst estimates of $275.99 million. Surgery Partners had a return on equity of 18.80% and a net margin of 2.63%. The company’s revenue was up 24.4% compared to the same quarter last year. Analysts anticipate that Surgery Partners Inc. will post $0.63 earnings per share for the current fiscal year.
Several analysts recently commented on the company. Zacks Investment Research cut Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday. Barclays PLC started coverage on Surgery Partners in a report on Wednesday, July 13th. They set an “equal weight” rating and a $20.00 price target on the stock. Finally, Jefferies Group restated a “buy” rating and set a $27.00 price target on shares of Surgery Partners in a report on Wednesday, August 10th. One research analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. Surgery Partners has an average rating of “Buy” and an average price target of $22.44.
In other Surgery Partners news, VP Jennifer Baldock sold 2,500 shares of Surgery Partners stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $19.20, for a total transaction of $48,000.00. Following the completion of the transaction, the vice president now owns 66,983 shares in the company, valued at approximately $1,286,073.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 7.10% of the company’s stock.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.